<DOC>
	<DOC>NCT01994668</DOC>
	<brief_summary>The purpose of this study is to evaluate safety, tolerability and pharmacokinetics of 2-mg lorazepam intravenous administration in healthy Japanese adult subjects.</brief_summary>
	<brief_title>Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Lorazepam</mesh_term>
	<criteria>Healthy Japanese male and/or female subjects of nonchildbearing potential. Body Mass Index of 17.5 to 30.5 kg/m2; and a total body weight &gt;50 kg. History of sensitivity to lorazepam or other benzodiazepines. Evidence or history of acute narrowangle glaucoma or sleep apnea syndrome. Significant psychiatric disorder, recurrent episodes of severe depression, or subjects with serious suicidal risk.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>lorazepam</keyword>
	<keyword>intravenous</keyword>
	<keyword>pharmacolinetics</keyword>
	<keyword>healthy</keyword>
	<keyword>Japanese</keyword>
</DOC>